About this trial
The study aims to assess the efficacy of culturally adapted dialectical behaviour therapy (DBT) for addressing emotional dysregulation in a low- and middle-income country, as well as to evaluate the impact of DBT on secondary outcomes such as borderline personality traits, self-harm or suicide, depression, anxiety, and individuals' functioning and disability.
Through a rigorous Randomised Controlled Trial (RCT), the research seeks to assess how cultural adaptations of dialectical behaviour therapy improve its applicability, engagement, and outcomes in diverse socio-cultural settings, contributing to more accessible and effective mental health interventions in resource-limited regions.
Eligibility criteria
Qualifiers
Adults aged 18-45 years
Adults who are diagnosed with or have significant traits of borderline personality disorder (BPD)
Adults who are willing to provide written informed consent
Disqualifiers
Severe psychiatric comorbidity (e.g., active psychosis, substance use, etc.)
Acute medical conditions interfering with participation
Lack of basic reading and writing, or any learning disability
Trial design
Treatments tested in this trial
- Culturally adapted DBT